Park Sang-Hyun, Han Sung-Hee, Do Sang-Hwan, Kim Jung-Won, Rhee Ka-young, Kim Jin-Hee
Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, 300 Gumi-dong, Seongnam City, Kyeonggi-do, 463-802, Korea.
Anesth Analg. 2008 Dec;107(6):1814-8. doi: 10.1213/ane.0b013e318185d093.
Postoperative sore throat and hoarseness are common complications after tracheal intubation, particularly after using a double-lumen endobronchial tube (DLT). We conducted a prospective, randomized, double-blind, placebo-controlled study to evaluate the efficacy of dexamethasone for reducing the incidence and severity of postoperative sore throat and hoarseness.
One hundred sixty-six patients (aged 18-75 yr) scheduled for thoracic surgery with a DLT were enrolled. Before induction of general anesthesia, 0.1 mg/kg dexamethasone (Group D1), 0.2 mg/kg dexamethasone (Group D2), or a placebo (Group P) were infused i.v. in a double-blind and prospectively randomized manner. Glottic exposure as defined by Cormack and Lehane score, resistance to DLT insertion, number of intubation attempts, time to achieve intubation, and the duration of tracheal intubation were recorded. At 1 h and 24 h after tracheal extubation, the patients were evaluated for sore throat and hoarseness using a visual analog scale (VAS; where 0 = no pain and 100 = worst pain imaginable).
One hour after tracheal extubation, the incidence of postoperative sore throat and hoarseness, along with the severity of sore throat were lower in Group D1 (31%, P = 0.021; 11%, P = 0.003; and VAS 12.4, P < 0.001, respectively) and D2 (11%, P = 0.001; 4%, P = 0.001; and VAS 6.6, P < 0.001, respectively) compared with Group P (53%, 36% and VAS 30.9, respectively). Twenty-four hours after tracheal extubation, the incidence of postoperative sore throat, hoarseness, and the severity of sore throat were significantly lower in Group D2 (27%, P = 0.002; 15%, P = 0.001; and VAS 29.9, P < 0.002, respectively) compared with Group D1 (47%, 31%, and VAS = 43.9, respectively) and Group P (57%, 45%, and VAS = 51.3, respectively). There was no complication associated with the dexamethasone administration.
The prophylactic use of 0.2 mg/kg of dexamethasone significantly decreases the incidence and severity of sore throat and hoarseness 1 h and 24 h after tracheal extubation of a DLT.
术后咽痛和声音嘶哑是气管插管后的常见并发症,尤其是在使用双腔支气管导管(DLT)后。我们进行了一项前瞻性、随机、双盲、安慰剂对照研究,以评估地塞米松在降低术后咽痛和声音嘶哑的发生率及严重程度方面的疗效。
纳入166例计划行胸科手术并使用DLT的患者(年龄18 - 75岁)。在全身麻醉诱导前,以双盲和前瞻性随机的方式静脉输注0.1mg/kg地塞米松(D1组)、0.2mg/kg地塞米松(D2组)或安慰剂(P组)。记录由Cormack和Lehane评分定义的声门暴露情况、DLT插入的阻力、插管尝试次数、插管所需时间以及气管插管持续时间。在气管拔管后1小时和24小时,使用视觉模拟评分法(VAS;0 = 无疼痛,100 = 可想象的最严重疼痛)对患者的咽痛和声音嘶哑情况进行评估。
气管拔管后1小时,D1组(分别为31%,P = 0.021;11%,P = 0.003;VAS为12.4,P < 0.001)和D2组(分别为11%,P = 0.001;4%,P = 0.001;VAS为6.6,P < 0.001)的术后咽痛和声音嘶哑发生率以及咽痛严重程度均低于P组(分别为53%、36%和VAS 30.9)。气管拔管后24小时,D2组(分别为27%,P = 0.002;15%,P = 0.001;VAS为29.9,P < 0.002)的术后咽痛、声音嘶哑发生率以及咽痛严重程度均显著低于D1组(分别为47%、31%和VAS = 43.9)和P组(分别为57%、45%和VAS = 51.3)。地塞米松给药未出现相关并发症。
预防性使用0.2mg/kg地塞米松可显著降低DLT气管拔管后1小时和24小时咽痛和声音嘶哑的发生率及严重程度。